VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
UNMUnum Group
$90.12$14.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksUNMFinancials

Unum Group (UNM) Financials

30Y historyFree accessUpdated daily

Revenue growth remains resilient at 9.0% as of 2026Q1, though underwriting profitability remains sensitive to claims volatility, evidenced by the combined ratio rising to 91.0% from a 2024Q3 low of 72.3%.

UNM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue13.3B13.05B12.79B12.31B11.88B11.84B13.15B11.99B11.6B11.29B11.05B10.73B10.52B10.37B10.52B10.28B10.19B10.09B9.98B10.52B10.54B10.44B10.46B9.82B9.08B9B9.07B9.33B8.52B7.68B4.07B
Revenue Growth %4.84%2.07%3.91%3.65%0.32%-9.96%9.63%3.4%2.76%2.18%2.94%1.96%1.5%-1.4%2.31%0.83%1.01%1.09%-5.11%-0.15%0.94%-0.26%6.58%8.08%0.91%-0.76%-2.77%9.51%10.97%88.55%-1.24%
Medical Costs & Claims8.79B8.07B8.05B8.28B7.95B8.52B10.06B8.57B9.03B8.02B7.87B7.69B8.16B7.46B7.55B8.01B7.16B6.89B8.07B8.39B7.63B8.07B8.24B8.99B7.14B6.73B6.92B8.07B6.53B5.39B2.05B
Medical Cost Ratio %66.11%61.78%62.91%67.24%66.91%71.98%76.52%71.46%77.82%71.02%71.24%71.68%77.56%71.92%71.81%77.95%70.25%68.23%80.85%79.71%72.39%77.28%78.76%91.59%78.65%74.73%76.29%86.52%76.66%70.25%50.3%
Gross Profit4.51B4.99B4.74B4.03B3.93B3.32B3.09B3.42B2.57B3.27B3.18B3.04B2.36B2.91B2.96B2.27B3.03B3.21B1.91B2.13B2.91B2.37B2.22B826M1.94B2.27B2.15B1.26B1.99B2.28B2.02B
Gross Margin %33.89%38.22%37.09%32.76%33.09%28.02%23.48%28.54%22.18%28.98%28.76%28.32%22.44%28.08%28.19%22.05%29.75%31.77%19.15%20.29%27.61%22.72%21.24%8.41%21.35%25.27%23.71%13.48%23.34%29.75%49.7%
Gross Profit Growth %-5.16%17.65%2.61%18.46%7.47%-9.8%33.05%-21.37%2.95%4.53%28.71%-18.88%-1.8%30.82%-25.28%-5.39%67.69%-10.43%-26.62%22.67%6.68%169.07%-57.41%-14.74%5.76%70.98%-36.75%-12.92%12.86%-33.1%
Operating Expenses3.52B4.06B2.49B2.39B2.18B2.06B2.12B2.04B1.94B1.87B1.83B1.8B1.82B1.69B1.72B1.93B1.71B1.91B1.09B1.14B2.44B1.66B2.48B1.28B1.36B1.52B1.33B1.42B1.07B801.1M-995.9M
OpEx / Revenue %26.43%31.07%19.49%19.44%18.36%17.37%16.15%17.01%16.76%16.54%16.56%16.79%17.29%16.31%16.31%18.81%16.81%18.96%10.9%10.81%23.19%15.92%23.72%13.02%15.03%16.89%14.66%15.26%12.54%10.43%-24.46%
Depreciation & Amortization93M123M116.1M108.8M110.5M119.8M113.6M110.1M101.4M103.4M101.7M99.5M87.9M84.8M84.3M81.1M75.4M74.5M68.8M66.2M80.5M87.8M80.5M761.8M510.3M573M594.9M653.7M492M138.9M75.1M
Combined Ratio %92.54%92.85%82.4%86.68%85.26%89.35%92.67%88.48%94.59%87.56%87.8%88.46%94.85%88.23%88.12%96.76%87.05%87.19%91.75%90.52%95.58%93.2%102.48%104.61%93.68%91.63%90.95%101.77%89.2%80.69%25.84%
Operating Income992.6M933.5M2.25B1.64B1.75B1.26B964M1.38B627.8M1.4B1.35B1.24B542M1.22B1.25B333.3M1.32B1.29B824M997.2M465.4M709.6M-259.5M-452.4M574.3M753.8M821.2M-165.5M920.2M1.48B3.02B
Operating Margin %7.46%7.15%17.6%13.32%14.74%10.65%7.33%11.52%5.41%12.44%12.2%11.54%5.15%11.77%11.88%3.24%12.95%12.81%8.25%9.48%4.42%6.8%-2.48%-4.61%6.32%8.37%9.05%-1.77%10.8%19.31%74.16%
Operating Income Growth %--58.54%37.27%-6.28%38.82%30.77%-30.25%120.15%-55.28%4.18%8.83%128.47%-55.57%-2.36%274.89%-74.75%2.14%56.83%-17.37%114.27%-34.41%373.45%42.64%-178.77%-23.81%-8.21%596.19%-117.99%-37.94%-50.89%9.39%
EBITDA1.09B1.06B2.37B1.75B1.86B1.38B1.08B1.49B729.2M1.51B1.45B1.34B629.9M1.3B1.33B414.4M1.4B1.37B892.8M1.06B545.9M797.4M-179M309.4M1.08B1.33B1.42B488.2M1.41B1.62B3.09B
EBITDA Margin %8.16%8.09%18.51%14.21%15.67%11.66%8.2%12.44%6.29%13.36%13.12%12.47%5.99%12.58%12.68%4.03%13.69%13.54%8.94%10.11%5.18%7.64%-1.71%3.15%11.94%14.74%15.61%5.23%16.58%21.12%76%
Interest Expense209.9M208.8M201.1M194.8M188.5M185M188.2M177.4M167.3M159.9M166M152.8M167.5M149.4M145.4M143.3M141.8M125.4M156.7M241.9M191.8M208M207.1M187.2M162.4M169.6M181.8M137.8M119.9M84.9M241.3M
Non-Operating Income-156.8M-208.8M-201.1M-194.8M-188.5M-185M-188.2M-177.4M-167.3M-159.9M-166M-152.8M-167.5M-149.4M-145.4M-143.3M-141.8M-125.4M-156.7M-241.9M-191.8M-208M-207.1M-204.4M-162.4M-169.6M-181.8M-137.8M-119.9M1.4B2.78B
Pretax Income992.6M933.5M2.25B1.64B1.75B1.26B964M1.38B627.8M1.4B1.35B1.24B542M1.22B1.25B333.3M1.32B1.29B824M997.2M465.4M709.6M-259.5M-452.4M574.3M753.8M821.2M-165.5M920.2M916.7M341.6M
Pretax Margin %7.46%7.15%17.6%13.32%14.74%10.65%7.33%11.52%5.41%12.44%12.2%11.54%5.15%11.77%11.88%3.24%12.95%12.81%8.25%9.48%4.42%6.8%-2.48%-4.61%6.32%8.37%9.05%-1.77%10.8%11.94%8.39%
Income Tax211.2M195M472.2M356.3M342.8M279.6M171M281.8M104.4M409.8M416.3M371.2M139.9M373M355.1M49.1M441.2M439.7M270.8M324.8M61.8M196M-67.3M-177.9M196.3M216.1M284M17.4M302.8M299.1M103.6M
Effective Tax Rate %21.28%20.89%20.97%21.72%19.59%22.18%17.74%20.39%16.63%29.19%30.89%29.98%25.81%30.57%28.42%14.73%33.43%34.02%32.86%32.57%13.28%27.62%25.93%39.32%34.18%28.67%34.58%-10.51%32.91%32.63%30.33%
Net Income781.4M738.5M1.78B1.28B1.41B981M793M1.1B523.4M994.2M931.4M867.1M402.1M847M894.4M284.2M878.7M852.6M553.2M679.3M411M513.6M-253M-386.4M401.2M541.2M538.9M-182.9M617.4M617.6M238M
Net Margin %5.87%5.66%13.91%10.43%11.85%8.29%6.03%9.17%4.51%8.81%8.43%8.08%3.82%8.17%8.51%2.77%8.62%8.45%5.54%6.46%3.9%4.92%-2.42%-3.94%4.42%6.01%5.94%-1.96%7.25%8.04%5.85%
Net Income Growth %-50.32%-58.49%38.58%-8.77%43.45%23.71%-27.93%110.22%-47.35%6.74%7.42%115.64%-52.53%-5.3%214.71%-67.66%3.06%54.12%-18.56%65.28%-19.98%303%34.52%-196.31%-25.87%0.43%394.64%-129.62%-0.03%159.5%-15.33%
EPS (Diluted)4.754.289.466.506.964.023.895.242.384.373.953.501.573.233.170.942.692.571.621.911.231.64-0.86-1.481.662.212.22-0.772.542.571.61
EPS Growth %-45.82%-54.76%45.54%-6.61%73.13%3.34%-25.76%120.17%-45.54%10.63%12.86%122.93%-51.39%1.89%237.23%-65.06%4.67%58.64%-15.18%55.28%-25%290.7%41.89%-189.16%-24.89%-0.45%388.31%-130.31%-1.17%59.63%-16.15%
EPS (Basic)-4.289.496.537.014.043.895.252.384.393.963.511.573.243.180.942.702.571.621.921.271.74-0.86-1.481.662.242.24-0.772.602.621.63
Diluted Shares Outstanding164.4M172.92M188.07M197.6M202.11M204.85M203.76M209.85M220.1M227.3M236M247.9M256.11M265.9M281.76M303.57M327.22M332.14M341.56M355.78M334.15M313.17M294.19M261.33M243.48M244.89M242.75M237.53M141.24M143.46M147.83M

Key Metrics

Growth RegimeStable
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Legacy LTC reserve volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Premium Growth Remains Modestly Resilient

As reported in recent financial filings, Unum Group achieved a 9.0% revenue growth rate in 2026Q1, signaling a stabilization in premium volume that appears to be supported by consistent demand within the core US group benefits segment despite broader macroeconomic uncertainty regarding the US labor market.

The recent acceleration in top-line growth suggests that the company's worksite marketing strategy is effectively capturing market share. Investors should monitor whether this momentum persists, as the company's revenue is fundamentally tethered to payroll growth and total insured lives.

Underwriting Profitability Subject To Volatility

Based on the provided income statement data, the combined ratio fluctuated significantly, reaching a low of 72.3% in 2024Q3 before rising to 91.0% in 2026Q1, which indicates that underwriting margins remain sensitive to periodic shifts in claims incidence and actuarial reserve adjustments.

The variance in the loss ratio, which spiked to 78.0% in 2025Q3, highlights the inherent difficulty in predicting long-term disability outcomes. While the combined ratio remains below the 100% threshold, the lack of consistent margin expansion warrants further investigation into the underlying drivers of claims volatility.

2024Q3 Anomaly Distorts Performance Trends

According to the historical data, 2024Q3 represented a major inflection point where the loss ratio plummeted to 3.0%, driving an outsized operating income of $886.4 million, a figure that appears to be an outlier rather than a sustainable shift in the company's core underwriting profitability.

This period likely reflects a significant reserve release or a non-recurring accounting adjustment that masks the true operational performance of the business. Analysts should treat this quarter as a statistical anomaly when modeling future earnings to avoid overestimating the company's long-term margin potential.

Legacy Liabilities Obscure Operational Health

Based on the reported figures, the persistent reliance on the Closed Block of legacy Long-Term Care policies continues to introduce non-cash earnings volatility, which may suggest that the company's reported net income is less reflective of current underwriting success than the headline figures might initially imply.

The market's persistent valuation discount for Unum compared to peers appears to be a rational response to the unpredictable nature of these legacy liabilities. Investors should remain cautious, as future reserve strengthening could necessitate significant capital charges that would directly impact the company's ability to maintain its current dividend and buyback pace.

UNM — Frequently Asked Questions

Quick answers to the most common questions about buying UNM stock.

What was Unum Group's (UNM) revenue in 2025?

For fiscal year 2025, Unum Group (UNM) reported total revenue of $13.05B. This represents a 220.6% increase compared to $4.07B in 1996.

Is Unum Group (UNM) profitable?

Unum Group (UNM) is profitable, generating $738.5M in net income for the fiscal year ending 2025 with a net profit margin of 5.7%.

What is Unum Group's operating profit margin?

Unum Group (UNM) reported an operating income of $933.5M, resulting in an operating profit margin of 7.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Unum Group's gross profit and gross margin?

Unum Group (UNM) generated $4.99B in gross profit for the year, representing a gross profit margin of 38.2%. This demonstrates the company's core pricing power and production efficiency.